agilon health, inc. (NYSE:AGL – Get Rating) has earned a consensus recommendation of “Buy” from the thirteen analysts that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have covered the stock in the last year is $37.64.
A number of equities research analysts have issued reports on AGL shares. Deutsche Bank Aktiengesellschaft reduced their price target on agilon health from $30.00 to $29.00 in a research report on Tuesday, January 25th. Zacks Investment Research raised agilon health from a “sell” rating to a “hold” rating in a research report on Friday, March 4th. Guggenheim initiated coverage on agilon health in a research note on Tuesday, March 29th. They set a “buy” rating and a $32.00 price target on the stock. Finally, SVB Leerink raised their price target on agilon health from $25.00 to $33.00 and gave the stock an “outperform” rating in a research note on Thursday, March 31st.
In related news, Director John William Wulf sold 30,808 shares of agilon health stock in a transaction on Tuesday, March 15th. The stock was sold at an average price of $19.10, for a total transaction of $588,432.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Benjamin Shaker sold 79,457 shares of the business’s stock in a transaction on Tuesday, March 15th. The stock was sold at an average price of $19.25, for a total value of $1,529,547.25. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 119,267 shares of company stock valued at $2,325,051.
agilon health stock traded up $0.73 during midday trading on Monday, reaching $19.50. 14,544 shares of the stock traded hands, compared to its average volume of 1,748,869. The company has a 50-day simple moving average of $22.09 and a two-hundred day simple moving average of $22.48. agilon health has a 12-month low of $14.36 and a 12-month high of $44.83. The firm has a market cap of $7.91 billion and a PE ratio of -18.02. The company has a current ratio of 3.83, a quick ratio of 3.83 and a debt-to-equity ratio of 0.04.
agilon health (NYSE:AGL – Get Rating) last announced its earnings results on Thursday, March 3rd. The company reported ($0.14) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.02). agilon health had a negative net margin of 22.17% and a negative return on equity of 17.01%. The firm had revenue of $462.89 million for the quarter, compared to analysts’ expectations of $453.53 million. Equities research analysts anticipate that agilon health will post -0.14 earnings per share for the current year.
agilon health Company Profile (Get Rating)
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.
- Get a free copy of the StockNews.com research report on agilon health (AGL)
- Schwab Stock Can Be Caught Down Here
- Snap Up Some Snap-On On Post-Earnings Weakness
- Time to Buy any Dip in Prologis Stock
- 3 Resilient Stocks to Buy for Retirement
- MarketBeat: Week in Review 4/18 – 4/22
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.